Urooncology Flashcards
What are the risk factors of prostate cancer?
- age (>65)
- familial and genetic factors (BRCA2, PTEN and TP53)
- hormones
- race (Afro-Carribean)
- geography (western)
What is the clinical presentation of prostate cancer?
Local:
- often asymptomatic (or raised PSA in screening)
- painful or slow micturition
- UTI
- haematuria
- urinary retention (anuria, uraemia)
- lymphoedema
Metastatic:
- bone pain
- renal failure
Describe the pathology of prostate carcinoma
- majority is primary adenocarcinoma in peripheral zone of prostate
- Gleason grading system used
- 6: well differentiated (25% 10y progression)
- 7: moderately differentiated (50% 10y progression)
- > 7: poorly differentiation (75% 10y progression)
- TNM staging classification
Describe the TNM staging of prostate cancer
- T1: no abnormality felt in prostate but tumour present within walls
- T2: abnormality felt on examination, raised PSA, still within wall of gland
- T3: tumour has burst through wall of gland
- T4: burst through prostate wall and involvement of adjacent structures
What is PSA and what does it do?
- serine protease secreted into seminal fluid
- liquifies seminal coagulation to hydrolyse semenogelins allowing release of sperm
- small amount released into circulation
What states will cause a rise in PSA?
- age
- size
- cancer
- inflammation, infection etc
What is the treatment of localised prostate cancer?
- watch and wait
- surveillance
- radiotherapy (external beam, conformal, brachytherapy)
- cryotherapy/HIFU
- TURP if symptomatic (surgical resection)
Describe the metastatic complications of prostate cancer and the signs of it
- spinal cord compression: urological emergency, severe pain, retention, constipation
- ureteric obstruction: anorexia, weight loss, raised creatinine
What is the treatment for advanced prostate cancer?
- androgen ablation therapy (medical castration - LHRH analogue) or surgical (orchidectomy)
- chemotherapy
- TURP for symptoms
- radiotherapy
What are the risk factors for bladder cancer?
- age (80+)
- race (white)
- environmental carcinogens
- chronic inflammation (stones, infection, long-term catheters etc.)
- drugs (eg. phenacetin, cyclophosphamide)
- pelvic radiotherapy
Describe the presentation and investigation of bladder cancer
- painless frank haematuria
- some with microscopic haematuria
- all require cystoscopy, renal US (kidney, urethra and bladder)
Describe the pathology of bladder cancer
- majority = transitional cell cancer (superficial 75% and invasive 25%
- squamous carcinoma
- adenocarcinoma
- secondary malignancies
Describe the treatment of bladder cancer
- urgent TURBT (surgical resection of tumour)
- CT intravenous urogram (look for upper tract involvement in renal pelvis)
- bimanual exam
- IV mitomycin to reduce recurrence
How are superficial bladder tumours treated to prevent recurrence?
- low grade superficial = low chance of recurrence but 6 week mitomycin can be given
- high grade superficiall = very high chance of recurrence, intravesical BCG immunotherapy
How is bladder cancer with muscle involvement treated?
- radical cystectomy or radiotherapy
- if widespread or multifocal radiotherapy not best choice
- Neo-adjuvant chemo